Family Medicine & Primary Care Review

Full text

2/2026 vol. 28
Original paper

Utilization of antibiotics in Bulgaria: a current review of market trends

Zornitsa Mitkova 1
,
Nikolina Miteva 1
,
Nikolay Gerasimov 2
,
Rumyana Simeonova 3
,
Guenka Petrova 1
,
Maria Dimitrova 1

  1. Department of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University Sofia, Sofia, Bulgaria

  2. Medical College, Trakia University, Stara Zagora, Bulgaria

  3. Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University Sofia, Sofia, Bulgaria

Family Medicine & Primary Care Review 2026; 28(2): 158–163

DOI: https://doi.org/10.5114/fmpcr.2026.159461
Data publikacji online: 2026/06/22
Article file
09 FM&PCR 2 26 - O - Mitkova - 1911 - Utilization.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A practical toolkit. Geneva: WHO; 2019.
  2. Ferraz MP. Antimicrobial Resistance: The Impact from and on Society According to One Health Approach. Societies 2024; 14(9): 187, doi: 10.3390/soc14090187.
  3. European Commission. A pharmaceutical strategy for Europe [cited 22.05.2025]. Available from URL: https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe_en.
  4. Aslam B, Asghar R, Muzammil S, et al. AMR and Sustainable Development Goals: at a crossroads. Glob Health 2024; 20(1): 73, doi: 10.1186/s12992-024-01046-8.
  5. Giubilini A. Antibiotic resistance as a tragedy of the commons: An ethical argument for a tax on antibiotic use in humans. Bioethics 2019; 33(7): 776–784.
  6. Abejew AA, Wubetu GY, Fenta TG. Antibiotic Prescribing Behavior of Physicians in Outpatient Departments in Hospi-tals in Northwest Ethiopia: Structural Equation Modeling Approach. Interact J Med Res 2024; 13: e57285, doi: 10.2196/57285.
  7. Lansink C, Sinha B, Meessen N, et al. Why Do Physicians Prescribe Antibiotics? A Systematic Review of the Psycho-Socio-Organisational Factors Related to Potentially Inappropriate Prescribing of Antimicrobials in Europe. Infect Dis Rep 2024; 16(4): 664–683, doi: 10.3390/idr16040051.
  8. Spernovasilis N, Ierodiakonou D, Milioni A, et al. Assessing the knowledge, attitudes and perceptions of junior doctors on antimicrobial use and antimicrobial resistance in Greece. J Glob Antimicrob Resist 2020; 21: 296–302, doi: 10.1016/j.jgar.2019.11.004.
  9. Wiboonchutikula C, Kim HB, Honda H, et al. Antibiotic pre-scribing behavior among physicians in Asia: a multinational survey. Antimicrob Steward Healthc Epidemiol 2023; 3(1): e112, doi: 10.1017/ash.2023.190.
  10. Orok E, Ikpe F, Williams T, et al. Impact of educational intervention on knowledge of antimicrobial resistance and antibiotic use patterns among healthcare students: a pre- and post-intervention study. BMC Med Educ 2025; 25(1): 283, doi: 10.1186/s12909-025-06856-x.
  11. WHO. Model Lists of Essential Medicines [cited 22.05.2025]. Available from URL: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists.
  12. Abdu N, Idrisnur S, Tewelde T, et al. Antibiotic prescribing practice using WHO Access, Watch and Reserve classification and its determinants among outpatient prescriptions dispensed to elderly population in six community chain pharmacies in Asmara, Eritrea: a cross-sectional study. BMJ Open 2024; 14(6): e085743, doi: 10.1136/bmjopen-2024-085743.
  13. Gashaw T, Yadeta TA, Weldegebreal F, et al. The global prevalence of antibiotic self-medication among the adult population: systematic review and meta-analysis. Syst Rev 2025; 14(1): 49, doi: 10.1186/s13643-025-02783-6.
  14. Almomani BA, Hijazi BM, Al-Husein BA, et al. Adherence and utilization of short-term antibiotics: Randomized con-trolled study. PLOS ONE 2023; 18(9): e0291050, doi: 10.1371/journal.pone.0291050.
  15. Charani E, Mendelson M, Pallett SJC, et al. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations. Lancet Glob Health 2023; 11(3): e466–e474, doi: 10.1016/S2214-109X(23)00019-0.
  16. Bulgaria, 2019 Update. APUA Bulgaria Action plan to combat antimicrobial resistance in Bulgaria (2020–2024) [cited 24.08.2025]. Available from URL: https://apua.org/bulgaria.
  17. Ruiz-Garbajosa P, Cantón R. COVID-19: Impact on prescribing and antimicrobial resistance. Rev Esp Quimioter 2021; Suppl. 1(Suppl. 1): 63–68, doi: 10.37201/req/s01.19.2021.
  18. OECD Embracing a One Health Framework to Fight Antimicrobial Resistance, OECD Health Policy Studies, OECD Publishing, Paris, 2023 [cited 22.05.2025]. Available from URL: https://doi.org/10.1787/ce44c755-en.
  19. Norwegian Institute of Public Health. ATC/DDD index. Antiinfectives for systemic use [cited 01.03.2025]. Available from URL: https://atcddd.fhi.no/atc_ddd_index/?code=J01CA04.
  20. World Health Organization Model List of Essential Medicines – 23rd List, 2023. In: The selection and use of essential medicines 2023: Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, 24 – 28 April 2023 Web Annex A. Geneva: WHO; 2023.
  21. How to investigate drug use in health facility? Selected drug use indicators. WHO/DAP/93.1; 1993. Available from URL: https://iris.who.int/server/api/core/bitstreams/83d355cb-89c2-4a43-8c1d-d6f07b56f365/content.
  22. Zaykova K, Nikolova SP, Pancheva R, et al. Antibiotic prescribing practices to children among in- and outpatient physicians in Bulgaria. Acta Medica Bulgarica 2025; 51(4): 33–40, doi: 10.2478/AMB-2024-0075.
  23. Nickel KB, Durkin MJ, Olsen MA, et al. CDC Prevention Epicenters Program. Utilization of broad- versus narrow-spectrum antibiotics for the treatment of outpatient community-acquired pneumonia among adults in the United States. Pharmacoepidemiol Drug Saf 2024; 33(4): e5779, doi: 10.1002/pds.5779.
  24. Tarrant C, Colman AM, Jenkins DR, et al. Drivers of Broad-Spectrum Antibiotic Overuse across Diverse Hospital Con-texts – A Qualitative Study of Prescribers in the UK, Sri Lanka and South Africa. Antibiotics 2021; 10(1): 94, doi: 10.3390/antibiotics10010094.
  25. Bruyndonckx R, Adriaenssens N, Versporten A, et al. Consumption of antibiotics in the community, European Un-ion/European Economic Area, 1997–2017. J Antimicrob Chemother 2021; 76(12 Suppl. 2): ii7–ii13, doi: 10.1093/jac/dkab172.
  26. Zahari NIN, Engku A, Rahman ENS, et al. A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae. Medicina 2023; 59(11): 1927, doi: 10.3390/medicina59111927.
  27. Moja L, Zanichelli V, Mertz D, et al. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections. Clin Microbiol Infect 2024; 30(Suppl. 2): S1–S51, doi: 10.1016/j.cmi.2024.02.003.
  28. Adekoya I, Maraj D, Steiner L, et. al. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study. Lancet Infect Dis 2021; 21(10): 1429–1440, doi: 10.1016/S1473-3099(20)30854-9.
  29. Hsia Y, Sharland M, Jackson C, et al. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries. Lancet Infect Dis 2019; 19(1): 67–75, doi: 10.1016/S1473-3099(18)30547-4.
  30. Cotia A, Oliveira Jr HA, Matuoka JY, et al. Clinical Equivalence between Generic Versus Branded Antibiotics: Systematic Review and Meta-Analysis. Antibiotics (Basel) 2023; 12(5): 935, doi: 10.3390/antibiotics12050935.
  31. Finch R. Generic antibiotics, antibiotic resistance, and drug licensing. Lancet Infect Dis 2010; 10(11): 754, doi: 10.1016/S1473-3099(10)70246-2.
Copyright: © 2026 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Integrated with